Contents

Search


neurofilament light chain in CSF

Indications: - marker for axonal damage [1] Clinical significance: - CSF levels associated with neurodegenerative disease & cognitive decline [1] - highest levels in patients with amyotrophic lateral sclerosis & frontotemporal dementia [1] - increases in CSF p-tau & CSF NFL in patients with Down syndrome in 4th decade of life [2]

Related

neurofilament light polypeptide; NF-L; neurofilament triplet L protein; 68 kD neurofilament protein (NEFL, NF68, NFL)

General

neurofilament light chain in body fluid

References

  1. Olsson B, Portelius E, Cullen NC et al Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. JAMA Neurol. 2018 Dec 3. PMID: 30508027 https://jamanetwork.com/journals/jamaneurology/fullarticle/2716834
  2. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: A cross-sectional study. Lancet 2020 Jun 27; 395:1988. PMID: 32593336 Free PMC article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30689-9/fulltext - Head E, Ances B. Biomarkers in Down syndrome can help us understand Alzheimer's disease. Lancet 2020 Jun 27; 395:1951 PMID: 32593327 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30916-8/fulltext